Corteva, Inc. (CTVA) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue grew from $14.29B (period ending 2018-12-31) to $17.40B (period ending 2025-12-31) — a 2.9% annual pace across 7 year(s) of filed history.
- Net margin turned from a loss (-35.5%) to a 6.3% margin over that same span.
- Across 26 tracked quarters, the strongest was $6.70B (quarter ending 2018-03-31) and the weakest was $1.86B (quarter ending 2020-09-30).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $17.40B | 2025-12-31 | 10-K | 0001755672-26-000004 |
| Net income | $1.09B | 2025-12-31 | 10-K | 0001755672-26-000004 |
| Diluted EPS | $1.60 | 2025-12-31 | 10-K | 0001755672-26-000004 |
| Total assets | $42.84B | 2025-12-31 | 10-K | 0001755672-26-000004 |
| Cash & equivalents | $4.52B | 2025-12-31 | 10-K | 0001755672-26-000004 |
| Operating cash flow | $3.41B | 2025-12-31 | 10-K | 0001755672-26-000004 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $6.38B | 2026-06-30 | 10-Q | 0001755672-26-000025 |
| Net income | $1.16B | 2026-06-30 | 10-Q | 0001755672-26-000025 |
| Diluted EPS | $1.73 | 2026-06-30 | 10-Q | 0001755672-26-000025 |
| Total assets | $41.64B | 2026-06-30 | 10-Q | 0001755672-26-000025 |
| Cash & equivalents | $2.37B | 2026-06-30 | 10-Q | 0001755672-26-000025 |
| Operating cash flow | $-2.89B | 2026-03-31 | 10-Q | 0001755672-26-000010 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
Corteva, Inc. (CTVA) operates with a substantial scale, as evidenced by its total assets of $42.84 billion and cash & equivalents of $4.52 billion at the end of 2025. The company’s revenue has grown from $14.29 billion in 2018 to $17.40 billion in 2025, reflecting a modest annual growth rate of 2.9% over seven years. This steady increase underscores the company’s established market presence and consistent demand for its agricultural products.
The company’s net income has transitioned from significant losses in its early years to a positive margin of 6.3% by 2025, demonstrating improved profitability. Notably, despite a strong revenue performance, the most recent quarterly filing (ending 2026-06-30) showed an operating cash flow deficit of $2.89 billion, which warrants observation in subsequent filings for context and potential explanations.
Investors should monitor Corteva’s ability to sustain profitability amidst fluctuating quarterly cash flows and the company’s strategic execution in managing its asset base to support future growth initiatives. The multi-year revenue trajectory indicates resilience but also suggests the need for continued operational efficiency to enhance margins and cash generation capabilities.
Source: SEC EDGAR company facts for CIK 0001755672 · filings index